Jazz Pharmaceuticals Enters Material Definitive Agreement
Ticker: JAZZ · Form: 8-K · Filed: Jul 22, 2024 · CIK: 1232524
| Field | Detail |
|---|---|
| Company | Jazz Pharmaceuticals PLC (JAZZ) |
| Form Type | 8-K |
| Filed Date | Jul 22, 2024 |
| Risk Level | medium |
| Pages | 4 |
| Reading Time | 4 min |
| Key Dollar Amounts | $0.0001, $289,564,455.52, $2,707,000,000 |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-definitive-agreement, financial-obligation
Related Tickers: JAZZ
TL;DR
Jazz Pharma signed a big deal, could mean new financial obligations.
AI Summary
On July 19, 2024, Jazz Pharmaceuticals plc entered into a material definitive agreement related to a financial obligation. The company, incorporated in Ireland, filed an 8-K report detailing this event. Specific details regarding the nature of the agreement and the financial obligation are not provided in this excerpt.
Why It Matters
This filing indicates Jazz Pharmaceuticals has entered into a significant agreement that may involve financial commitments, potentially impacting its financial structure and future operations.
Risk Assessment
Risk Level: medium — Entering into material definitive agreements can introduce new financial obligations or strategic shifts that carry inherent risks.
Key Players & Entities
- Jazz Pharmaceuticals plc (company) — Registrant
- July 19, 2024 (date) — Date of earliest event reported
FAQ
What type of material definitive agreement did Jazz Pharmaceuticals plc enter into?
The filing indicates Jazz Pharmaceuticals plc entered into a material definitive agreement, but the specific nature of the agreement is not detailed in this excerpt.
What is the date of the earliest event reported in this 8-K filing?
The date of the earliest event reported is July 19, 2024.
Where is Jazz Pharmaceuticals plc incorporated?
Jazz Pharmaceuticals plc is incorporated in Ireland.
What is the SEC file number for Jazz Pharmaceuticals plc?
The SEC file number for Jazz Pharmaceuticals plc is 001-33500.
What is the IRS Employer Identification Number for Jazz Pharmaceuticals plc?
The IRS Employer Identification Number for Jazz Pharmaceuticals plc is 98-1032470.
Filing Stats: 1,061 words · 4 min read · ~4 pages · Grade level 10.1 · Accepted 2024-07-22 07:57:32
Key Financial Figures
- $0.0001 — istered Ordinary shares, nominal value $0.0001 per share JAZZ The Nasdaq Stock Mar
- $289,564,455.52 — lar Term Loans ") and Jazz Lux borrowed $289,564,455.52 aggregate principal amount of additiona
- $2,707,000,000 — g the Repricing Amendment, each totaled $2,707,000,000. The Tranche B-2 Dollar Term Loans be
Filing Documents
- d813284d8k.htm (8-K) — 27KB
- d813284dex101.htm (EX-10.1) — 1331KB
- 0001193125-24-181938.txt ( ) — 1801KB
- jazz-20240719.xsd (EX-101.SCH) — 3KB
- jazz-20240719_lab.xml (EX-101.LAB) — 18KB
- jazz-20240719_pre.xml (EX-101.PRE) — 11KB
- d813284d8k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. JAZZ PHARMACEUTICALS PUBLIC LIMITED COMPANY By: /s/ Philip L. Johnson Name: Philip L. Johnson Title: Executive Vice President and Chief Financial Officer Date: July 22, 2024